<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee18afe0c4f">
    <name type="corporate">
         <namePart>United States Government Publishing Office</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
              <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
         <role>
              <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
              <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>House of Representatives</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">author</roleTerm>
              <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
         <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
         <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
         <collectionCode>BILLS</collectionCode>
         <searchTitle>To amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing.;Improving Regulatory Transparency for New Medical Therapies Act;H.R. 639 (IH)
    </searchTitle>
         <category>Bills and Statutes</category>
         <waisDatabaseName>114_cong_bills</waisDatabaseName>
         <branch>legislative</branch>
         <dateIngested>2015-02-07</dateIngested>
    </extension>
    <titleInfo>
         <title>To amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing.</title>
    </titleInfo>
    <titleInfo type="alternative">
         <title>Improving Regulatory Transparency for New Medical Therapies Act</title>
    </titleInfo>
    <titleInfo type="alternative">
         <title>H.R. 639 (IH)
    </title>
    </titleInfo>
    <originInfo>
         <publisher>U.S. Government Publishing Office</publisher>
         <dateIssued encoding="w3cdtf">2015-02-02</dateIssued>
         <issuance>monographic</issuance>
    </originInfo>
    <physicalDescription>
         <note type="source content type">deposited</note>
         <digitalOrigin>born digital</digitalOrigin>
         <extent>3 p.</extent>
    </physicalDescription>
    <classification authority="sudocs">Y 1.6:</classification>
    <classification authority="sudocs">Y 1.4/6:</classification>
    <identifier type="local">P0b002ee18afe0c4f</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/BILLS-114hr639ih</identifier>
    <identifier type="preferred citation">H.R. 639</identifier>
    <identifier type="stock number">021-610-00252-9</identifier>
    <identifier type="Parent ILS system id">000501532</identifier>
    <identifier type="Child ILS system id">000325573</identifier>
    <identifier type="Parent ILS title">Congressional bills</identifier>
    <identifier type="Child ILS title">House bills</identifier>
    <identifier type="former package identifier">f:h639_ih.txt</identifier>
    <location>
         <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/BILLS-114hr639ih</url>
         <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-114hr639ih/html/BILLS-114hr639ih.htm</url>
         <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-114hr639ih/pdf/BILLS-114hr639ih.pdf</url>
         <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-114hr639ih/xml/BILLS-114hr639ih.xml</url>
    </location>
    <accessCondition type="GPO scope determination">fdlp</accessCondition>
    <recordInfo>
         <recordContentSource authority="marcorg">DGPO</recordContentSource>
         <recordCreationDate encoding="w3cdtf">2015-02-07</recordCreationDate>
         <recordChangeDate encoding="w3cdtf">2023-01-06</recordChangeDate>
         <recordIdentifier source="DGPO">BILLS-114hr639ih</recordIdentifier>
         <recordOrigin>machine generated</recordOrigin>
         <languageOfCataloging>
              <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
        </languageOfCataloging>
    </recordInfo>
    <name type="personal">
         <namePart>Joseph R. Pitts</namePart>
         <affiliation>United States House of Representatives</affiliation>
         <role>
              <roleTerm authority="marcrelator" type="text">sponsor</roleTerm>
              <roleTerm authority="marcrelator" type="code">spn</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="personal">
         <namePart>Frank Pallone, Jr.</namePart>
         <affiliation>United States House of Representatives</affiliation>
         <role>
              <roleTerm type="text">cosponsor</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="personal">
         <namePart>Gene Green</namePart>
         <affiliation>United States House of Representatives</affiliation>
         <role>
              <roleTerm type="text">cosponsor</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>House of Representatives</namePart>
         <namePart>Committee on Energy and Commerce</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">associated name</roleTerm>
              <roleTerm authority="marcrelator" type="code">asn</roleTerm>
        </role>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>House of Representatives</namePart>
         <namePart>Committee on the Judiciary</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">associated name</roleTerm>
              <roleTerm authority="marcrelator" type="code">asn</roleTerm>
        </role>
    </name>
    <relatedItem type="isReferencedBy">
         <titleInfo>
              <title>United States Code</title>
              <partNumber>Title 21 Section 811(a)</partNumber>
              <partNumber>Title 21 Section 823</partNumber>
        </titleInfo>
         <identifier type="USC citation">21 U.S.C. 811(a)</identifier>
         <identifier type="USC citation">21 U.S.C. 823</identifier>
    </relatedItem>
    <extension>
         <docClass>hr</docClass>
         <accessId>BILLS-114hr639ih</accessId>
         <congress>114</congress>
         <session>1</session>
         <originChamber>HOUSE</originChamber>
         <currentChamber>HOUSE</currentChamber>
         <billNumber>639</billNumber>
         <billVersion reprint="false">ih</billVersion>
         <fileSuffix>ih</fileSuffix>
         <shortTitle type="measure">Improving Regulatory Transparency for New Medical Therapies Act</shortTitle>
         <officialTitle>To amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing.</officialTitle>
         <action date="2015-02-02">Mr. Pitts (for himself, Mr. Pallone, and Mr. Gene Green of Texas) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action>
         <congCommittee authorityId="hsif00" chamber="H" congress="114" type="S">
                                
              <name type="authority-standard">Committee on Energy and Commerce</name>
                                
              <name type="authority-short">Energy and Commerce</name>
                            
        </congCommittee>
         <congCommittee authorityId="hsju00" chamber="H" congress="114" type="S">
                                
              <name type="authority-standard">Committee on the Judiciary</name>
                                
              <name type="authority-short">Judiciary</name>
                            
        </congCommittee>
         <congMember bioGuideId="P000373" chamber="H" congress="114" party="R" role="SPONSOR" state="PA">
                                
              <name type="parsed">Mr. Pitts</name>
                                
              <name type="authority-fnf">Joseph R. Pitts</name>
                                
              <name type="authority-lnf">Pitts, Joseph R.</name>
                                
              <name type="authority-other">Joseph Pitts</name>
                            
        </congMember>
         <congMember bioGuideId="P000034" chamber="H" congress="114" party="D" role="COSPONSOR" state="NJ">
                                
              <name type="parsed">Mr. Pallone</name>
                                
              <name type="authority-fnf">Frank Pallone, Jr.</name>
                                
              <name type="authority-lnf">Pallone, Frank, Jr.</name>
                                
              <name type="authority-other">Frank Pallone</name>
                            
        </congMember>
         <congMember bioGuideId="G000410" chamber="H" congress="114" party="D" role="COSPONSOR" state="TX">
                                
              <name type="parsed">Mr. Gene Green of Texas</name>
                                
              <name type="authority-fnf">Gene Green</name>
                                
              <name type="authority-lnf">Green, Gene</name>
                            
        </congMember>
         <isPrivate>false</isPrivate>
         <isAppropriation>false</isAppropriation>
         <USCode title="21">
                                
              <section detail="(a)" number="811"></section>
                                
              <section number="823"></section>
                            
        </USCode>
    </extension>
</mods>